Loading company…
Shanghai respiratory drug developer making metered dose, dry powder and nebulizer inhalers for asthma and COPD.
Shanghai Omni Pharmaceutical Co., Ltd was established in 2011 and is based in Shanghai, China. It focuses on respiratory drug delivery technology and innovative drug development, with metered dose inhalers, dry powder inhalers, inhaled nebulizing solutions and nasal sprays for asthma and chronic obstructive pulmonary disease. Products are sold through hospitals, retail pharmacies and e-commerce platforms. Chairman Kai Zhang was formerly director of product development at IVAX Corporation, and the company closed a series D+ round in November 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in